Monitoring and Early Response Evaluation Using HPV DNA – A Study on Patients With HPV-positive Throat Cancer (MER-HPV)
Condition(s):Oropharynx Squamous Cell CarcinomaLast Updated:April 6, 2023Not yet recruiting
Hide Studies Not Open or Pending
Condition(s):Oropharynx Squamous Cell CarcinomaLast Updated:April 6, 2023Not yet recruiting
Condition(s):Head and Neck Cancer; HPV (Human Papillomavirus)-Associated Carcinoma; OropharyngealLast Updated:November 6, 2018Completed
Condition(s):Oropharyngeal Squamous Cell CarcinomaLast Updated:November 18, 2022Active, not recruiting
Condition(s):Squamous Cell Carcinoma of the Oral Cavity; Squamous Cell Carcinoma of the OropharynxLast Updated:September 22, 2016Completed
Condition(s):Head and Neck CancerLast Updated:May 4, 2006Completed
Condition(s):Head and Neck CancerLast Updated:January 16, 2012Withdrawn
Condition(s):Cranial Nerve Disorder; Head and Neck Carcinoma; Oropharyngeal CarcinomaLast Updated:November 14, 2022Recruiting
Condition(s):Head and Neck Cancer; Carcinoma, Squamous Cell; Neoplasms, Oral; Neoplasms, PharyngealLast Updated:March 17, 2022Completed
Condition(s):Head and Neck CancerLast Updated:January 5, 2017Unknown status
Condition(s):Head and Neck Cancer; Infection; Precancerous ConditionLast Updated:January 17, 2019Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.